Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 11, 2021

SELL
$5.35 - $7.77 $412,736 - $599,432
-77,147 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$7.22 - $9.11 $23,955 - $30,226
3,318 Added 4.49%
77,147 $584,000
Q2 2020

Aug 13, 2020

BUY
$4.93 - $10.26 $363,976 - $757,485
73,829 New
73,829 $639,000
Q4 2019

Feb 11, 2020

SELL
$5.02 - $6.66 $790,524 - $1.05 Million
-157,475 Closed
0 $0
Q3 2019

Nov 13, 2019

BUY
$4.98 - $6.7 $202,576 - $272,542
40,678 Added 34.83%
157,475 $965,000
Q2 2019

Aug 14, 2019

BUY
$3.15 - $6.95 $367,910 - $811,739
116,797 New
116,797 $731,000

Others Institutions Holding DYAI

About DYADIC INTERNATIONAL INC


  • Ticker DYAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,423,100
  • Market Cap $49.7M
  • Description
  • Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vac...
More about DYAI
Track This Portfolio

Track Eam Investors, LLC Portfolio

Follow Eam Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Investors, LLC with notifications on news.